The Research and Development team at Alaunos Therapeutics is focused on pioneering advancements in cellular immuno-oncology, specifically through the innovative application of adoptive TCR-T cell therapy for treating solid tumors. This team collaborates on designing and executing clinical trials, optimizing therapeutic techniques, and ensuring regulatory compliance to bring cutting-edge therapies from the laboratory to the clinic. Their expertise spans gene and cell therapy, leading strategic initiatives that drive scientific discovery and improve patient outcomes.